Open Access<p>Efficacy And Safety Of Raltitrexed Plus Oxaliplatin-Based Transarterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma</p>
Author(s) -
Wenyu Shao,
Caixia Li,
Jun Tang,
Jukun Song,
Zixiang Li,
Jingchao Sun,
Yili Xu,
Zhaomin Zheng,
Jingqin Cao,
Lei Zhang
Publication year - 2019
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s217524
Subject(s) - medicine , raltitrexed , oxaliplatin , hepatocellular carcinoma , gastroenterology , proportional hazards model , clinical endpoint , adverse effect , oncology , cancer , colorectal cancer , clinical trial
To evaluate the efficacy and safety of raltitrexed plus oxaliplatin-based transarterial chemoembolization (TACE) in patients with unresectable hepatocellular carcinoma (HCC).